XML 32 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (13,000) $ (11,506)
Adjustment to reconcile net loss to net cash:    
Depreciation and amortization 637 657
Provision for bad debt 93 126
Impairment of assets 3,448 0
Common stock-based compensation and expenses, net 1,773 2,843
Profit/Loss on sale of fixed assets, net (44) 39
Changes in:    
Accounts receivables, net (25) 5
Inventory 1,008 897
Deposits and advances 150 591
Claims and advances 315 (150)
Accounts payable 243 (451)
Accrued and other liabilities 197 (88)
Operating lease asset 129 124
Operating lease liability (123) (134)
Net cash used in operating activities (5,199) (7,047)
Cash flow from investing activities:    
Purchase of property, plant, and equipment (138) (310)
Sale of property, plant, and equipment 44 538
Proceeds from (Purchase of) short-term investments 154 (154)
Acquisition and development of intangible assets (377) (309)
Net cash used in investing activities (317) (235)
Cash flows from financing activities:    
Net proceeds from the issuance of common stock 3,027 103
Proceeds from common stock subscribed 500 0
Repayment of long-term loan (3) (3)
Net cash provided by financing activities 3,524 100
Effects of exchange rate changes on cash and cash equivalents (6) (82)
Net decrease in cash and cash equivalents (1,998) (7,264)
Cash and cash equivalents at the beginning of the period 3,196 10,460
Cash and cash equivalents at the end of the period 1,198 3,196
Non-cash items:    
Common stock issued/granted for stock-based compensation, including patent acquisition $ 1,773 $ 2,843